Results 101 to 110 of about 6,396 (177)

The effects of deferiprone and deferasirox on the structure and function of β-thalassemia hemoglobin [PDF]

open access: yes
Transfusional iron overload is a major cause of morbidity and mortality in thalassemia, sickle-cell disease and other chronic anemias. To overcome these problems, orally bio available iron chelators, deferiprone and deferasirox, were used for the ...
دیوسالار, عادله   +14 more
core  

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias. [PDF]

open access: yesBlood Adv
Sheth S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy